Ides of March, page-8

First 8 Last

Share
Profile

Follow
Singa71

517 Posts.

12/03/16

12:47

Post #: 17258403
Share

Originally posted by viney402 ↑

At least management can't say the disquiet on HC is unwarranted.

Their own auditors are driving the concern.

Only management can put the market at ease

Viney

"The financial report has been prepared on a going concern basis. In arriving at this position, the Directors have had regard to the fact that the Group will have access to sufficient working capital to fund administrative and other committed expenditure for a period of not less than 12 months from the date of this report. The Group’s cash resources and positive forecasted operating cash inflows for the 15 months ending 31 March 2017 are sufficient to cover working capital requirements and to fund the Group’s investing activities, but not sufficient to cover the repayment of the Group’s external debt of $15,067,896 as at 31 December 2015. The Group is currently progressing a reserve based lending facility, which can be used to finance the current debt commitments. The Directors are confident of being able to raise the required finance, but note that although the reserve based lending process is far advanced it has not yet been finalised at the date of this report. Should the reserve based lending facility not be attained, the directors will seek alternative fund raising activities, which may include divestment of assets. Should the Group not achieve financing, either through the reserve based lending facility or alternative asset divestments, there is uncertainty whether the Group would continue as a going concern and therefore whether it would realise its assets and extinguish its liabilities in the normal course of business and at the amounts stated in the financial report. The financial report does not include adjustments relating to the recoverability or classification of the recorded assets amounts nor to the amounts or classification of liabilities that might be necessary should the Group not be able to continue as a going concern."

Expand

Viney exactly, there's more concerns than positives.

EGO Price at posting: 38.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

There are more pages in this discussion • 9 more messages in this thread...

First 8 Last

Add EGO (ASX) to my watchlist

Ides of March, page-8

Top Stories

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Nimy to raise $1.21M to explore 'newsy' WA targets

Immutep reports strong response rate from immunotherapies treating carcinomas

Featured News